Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Variable charge X-linked protein 3 (VCX3A) is a small, highly charged nuclear protein encoded by the VCX3A gene, a member of the VCX/Y family found on the X chromosome and expressed primarily in male germ cells and brain tissues[1][2][4][5][7]. VCX3A acts as a noncanonical cap-binding protein that regulates mRNA stability by binding to the 5′ cap of mRNAs and inhibiting the decapping enzyme hDcp2, thereby protecting transcripts from degradation[1][4]. Studies have implicated VCX3A in neurodevelopment, including cognitive function and neuronal differentiation. Deletions or mutations affecting VCX3A have been associated with neurodevelopmental disorders such as X-linked mental retardation and possibly autism spectrum disorder[2][4]. The biological function of VCX3A remains incompletely understood, but evidence indicates roles in the regulation of gene expression at the post-transcriptional level and potential involvement in spermatogenesis[1][2][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Variable charge X-linked protein 3 (VCX3A).